Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Measurement of the lifetime difference in D0 meson decays.
Physical review letters·2002
Production of prompt charmonia in e(+)e(-) annihilation at square root of s approximately equals 0.6 GeV.
Physical review letters·2002
Observation of the color-suppressed decay B( 0)-->D(0)pi(0).
Physical review letters·2002
[Pulmonary involvement, pleural effusion, and electrocardiographic abnormality in hypereosinophilic syndrome].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society·2002
Observation of B+ --> chi(c0)K+.
Physical review letters·2002
Observation of the decay B --> Kl+l-.
Physical review letters·2002
Gene-deletion and carrier detections, and prenatal diagnosis of Duchenne muscular dystrophy by analysis of the dystrophin gene amplified by polymerase chain reaction.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
Rapid detection of a point mutation in thyroid-stimulating hormone beta-subunit gene causing congenital isolated thyroid-stimulating hormone deficiency.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
Biochemical characteristics of glucose-6-phosphate dehydrogenase variants among the Malays of Singapore with report of a new non-deficient (GdSingapore) and three deficient variants.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
Similar proportion of sporadic cases in cytochrome b558 negative chronic granulomatous disease and Duchenne muscular dystrophy.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
The MspI restriction fragment length polymorphism of human aldolase B gene on chromosome 9q21.3-q22.2.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
The prevalence at birth of cogenital malformations at a maternity hospital in Osaka City, 1948-1990.
Jinrui idengaku zasshi. The Japanese journal of human genetics·1991
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.
Therapeutic advances in endocrinology and metabolism·2026
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Drug design, development and therapy·2026
Evaluation of muscle microvascular perfusion in primary mitochondrial disease by contrast-enhanced ultrasound: Feasibility study.
Therapeutic advances in rare disease·2026